Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Glucocorticoids interfere with mycophenolate mofetil bioavailability in kidney transplantation — Dario Cattaneo (2002) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Glucocorticoids interfere with mycophenolate mofetil bioavailability in kidney transplantation
Shared by
Giuseppe Remuzzi
Glucocorticoids interfere with mycophenolate mofetil bioavailability in kidney transplantation
Article
2002
en
Authors
+2 more
DC
Dario Cattaneo
NP
Norberto Perico
FG
Flavio Gaspari
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Letter
2008
Pharmacokinetic/Pharmacodynamic Drug Interaction Between Rosiglitazone and Mycophenolate Mofetil in Kidney Transplantation
Dario Cattaneo
,
Alessandra Bitto
,
Sara Baldelli
,
Monica Cortinovis
,
Eliana Gotti
,
Norberto Perico
,
Giuseppe Remuzzi
Letter
2009
Mycophenolate Mofetil Versus Azathioprine in Organ Transplantation
Paolo Cravedi
,
Annalisa Perna
,
Piero Ruggenenti
,
Giuseppe Remuzzi
Letter
2006
Is Mycophenolate Mofetil Better Than Azathioprine in Organ Transplantation?
Piero Ruggenenti
,
Giuseppe Remuzzi
Article
2016
Efficacy and Safety of Monotherapy With Mycophenolate Mofetil in Liver Transplantation Patients With Nephrotoxicity
Cristina Miranda Cruz
,
Sheila Pereira
,
Jesus Simal Gandara
,
Sónia Ferreira
,
Vítor Lopes
,
J. Daniel
,
Helena Miranda
Article
2001
Pharmacokinetics help optimizing mycophenolate mofetil dosing in kidney transplant patients
Dario Cattaneo
,
Flavio Gaspari
,
Silvia Ferrari
,
Nadia Stucchi
,
Laura Del Priore
,
Norberto Perico
,
Eliana Gotti
,
Giuseppe Remuzzi
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.